These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734 [TBL] [Abstract][Full Text] [Related]
3. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency. Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292 [TBL] [Abstract][Full Text] [Related]
4. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects. Costa-Barbosa FA; Carvalho VM; Oliveira KC; Vieira JGH; Kater CE Clin Endocrinol (Oxf); 2021 Oct; 95(4):677-685. PubMed ID: 34231242 [TBL] [Abstract][Full Text] [Related]
5. Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency. Yildiz M; Isik E; Abali ZY; Keskin M; Ozbek MN; Bas F; Ucakturk SA; Buyukinan M; Onal H; Kara C; Storbeck KH; Darendeliler F; Cayir A; Unal E; Anik A; Demirbilek H; Cetin T; Dursun F; Catli G; Turan S; Falhammar H; Baris T; Yaman A; Haklar G; Bereket A; Guran T J Clin Endocrinol Metab; 2021 Aug; 106(9):e3714-e3724. PubMed ID: 33830237 [TBL] [Abstract][Full Text] [Related]
6. Expanding genetic spectrum and discriminatory role of steroid profiling by LC-MS/MS in 11β-hydroxylase deficiency. Karlekar MP; Sarathi V; Lila A; Rai K; Arya S; Bhandare VV; Atluri S; Patil V; Ramteke-Jadhav S; Shah NS; Kunwar A; Bandgar T Clin Endocrinol (Oxf); 2021 Apr; 94(4):533-543. PubMed ID: 33275286 [TBL] [Abstract][Full Text] [Related]
7. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess. Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001 [TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants. Fylaktou I; Smyrnaki P; Sertedaki A; Dracopoulou M; Kanaka-Gantenbein C Hormones (Athens); 2022 Mar; 21(1):155-161. PubMed ID: 34697763 [TBL] [Abstract][Full Text] [Related]
9. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. Claahsen-van der Grinten HL; Otten BJ; Sweep FC; Span PN; Ross HA; Meuleman EJ; Hermus AR J Clin Endocrinol Metab; 2007 Sep; 92(9):3674-80. PubMed ID: 17595257 [TBL] [Abstract][Full Text] [Related]
10. Typical characteristics of children with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: a single-centre experience and review of the literature. Breil T; Yakovenko V; Inta I; Choukair D; Klose D; Mittnacht J; Schulze E; Alrajab A; Grulich-Henn J; Bettendorf M J Pediatr Endocrinol Metab; 2019 Mar; 32(3):259-267. PubMed ID: 30817301 [TBL] [Abstract][Full Text] [Related]
11. Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers. Costa-Barbosa FA; Carvalho VM; Nakamura OH; Bachega TA; Vieira JG; Kater CE J Endocrinol Invest; 2011 Sep; 34(8):587-92. PubMed ID: 20924223 [TBL] [Abstract][Full Text] [Related]
12. A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism. Reisch N; Högler W; Parajes S; Rose IT; Dhir V; Götzinger J; Arlt W; Krone N J Clin Endocrinol Metab; 2013 Oct; 98(10):E1620-5. PubMed ID: 23940125 [TBL] [Abstract][Full Text] [Related]
13. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol. Miller WL Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227 [TBL] [Abstract][Full Text] [Related]
15. Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient. Ozbas B; Demir M; Dursun H; Sahin I; Hacioglu A; Karaca Z; Dundar M; Unluhizarci K Endocr Metab Immune Disord Drug Targets; 2023; 23(5):721-726. PubMed ID: 36214299 [TBL] [Abstract][Full Text] [Related]
17. Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Müssig K; Kaltenbach S; Maser-Gluth C; Hartmann MF; Wudy SA; Horger M; Gallwitz B; Raue F; Häring HU; Schulze E Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):208-14. PubMed ID: 16705555 [TBL] [Abstract][Full Text] [Related]
18. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467 [TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Bulsari K; Falhammar H Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728 [TBL] [Abstract][Full Text] [Related]